Graphite Bio: Of The Current Report On Form 8k Filed On August 23, 2023 (the Original Form 8k ) To Disclose Information Regarding Material Modifications To A Material Compensatory Plan, Contract Or Arrangement As To Which A Named Executive Officer Of The Registrant Participates That Were Effected Pursuant To An Agreement Entered Into Subsequent To The Filing Of The Original Form 8k. No Other Changes Have Been Made To The Original Form 8k
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameLENZ Therapeutics Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









